{
    "clinical_study": {
        "@rank": "134559", 
        "acronym": "IRCSMBO", 
        "arm_group": [
            {
                "arm_group_label": "Stenting combined with brachytherapy", 
                "arm_group_type": "Experimental", 
                "description": "A self-expandable metallic biliary stent loaded with 125 iodine seeds is inserted in patients with inoperable biliary obstruction caused by cholangioma."
            }, 
            {
                "arm_group_label": "Stenting only", 
                "arm_group_type": "Active Comparator", 
                "description": "A self-expandable metallic biliary stent is inserted in patients with inoperable biliary obstruction caused by cholangioma."
            }
        ], 
        "brief_summary": {
            "textblock": "Stenting the biliary obstruction is considered to be the preferred palliation modality to\n      relieve pruritus,cholangitis,pain and jaundice in patients without surgical indications of\n      malignant biliary obstruction.An unicentral clinical trial has demonstrated the safety and\n      technical feasibility of an irradiation biliary stent insertion in patients with biliary\n      obstruction caused by adenocarcinomas, such a treatment seems have benefits in relieving\n      jaundice and extending survival when compared to a conventional biliary stent.However,the\n      small sample size,the population distribution of two groups will influence the final results\n      in obtaining a powerful statistical conclusion.Therefore,a multicentric study was designed\n      to prospectively compared the responses to the treatment with this irradiation biliary stent\n      versus the conventional biliary self-expandable stent in patients with inoperable biliary\n      obstruction caused by cholangiocarcinoma."
        }, 
        "brief_title": "IRS(Irradiation Stent) vs. CS(Conventional Stent) Insertion in Inoperable Malignant Biliary Obstruction", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Cholangiocarcinoma", 
        "condition_browse": {
            "mesh_term": "Cholangiocarcinoma"
        }, 
        "detailed_description": {
            "textblock": "Biliary obstruction is a common condition caused by various carcinomas.The clinical process\n      is usually silent and insidious,only 10-20% patients can be surgically removed once\n      obstructive jaundice occurred.The long-term survival rate after resection remain\n      dismal.Relief of obstructive jaundice plays major role on prognosis in patients without\n      surgical indications.For unresectable patients,stenting the biliary obstruction is\n      considered to be the preferred palliation modality to relieve pruritus,cholangitis,pain and\n      jaundice.Although a number of new techniques for treatment of malignant biliary obstruction\n      have been developed,there have been no significant differences in survival or quality of\n      life comparing surgery bypass versus plastic stent insertion,metal stent insertion versus\n      plastic stents insertion,or covered stent versus uncovered stents insertion in such\n      patients.Our previous unicentric clinical trial has demonstrated the safety and technical\n      feasibility of a biliary intraluminal irradiation stent insertion in patients with biliary\n      obstruction caused by adenocarcinomas, such a treatment seems have benefits in relieving\n      jaundice and extending survival when compared to a conventional biliary stent.However,the\n      small sample size,the population distribution of two groups will influence the final results\n      in obtaining a powerful statistical conclusion in the overall survival and stent patency\n      between two groups.Therefore,a multicentric study was designed to prospectively compared the\n      responses to the treatment with this irradiation biliary stent versus the conventional\n      biliary self-expandable stent in patients with inoperable biliary obstruction caused by\n      cholangiocarcinoma."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical,histological or pathological diagnosis of cholangioma\n\n          -  Unresectability or refusal to be surgically treated\n\n          -  The Eastern Cooperative Oncology Group(ECOG) scores from 0 to 3\n\n          -  With symptoms such as jaundice related to biliary obstruction\n\n          -  Willing and able to comply with the study procedures and provide written  informed\n             consent to participate in the study\n\n          -  Biliary obstruction of Bismuthe-Corlette,type I and II\n\n        Exclusion Criteria:\n\n          -  Benign biliary obstruction\n\n          -  The Eastern Cooperative Oncology Group(ECOG) score of 4\n\n          -  Biliary tract stricture that could not be dilated enough to pass the delivery system\n\n          -  Presence of metallic biliary stent or bile duct surgery\n\n          -  Percutaneous transhepatic cholangiography(PTC) procedure was contraindicated\n\n          -  Active hepatitis\n\n          -  Biliary obstruction of Bismuthe-Corlette,type \u2162 and \u2163\n\n          -  Uncooperative or could not provide authorization and signature"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "238", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02001779", 
            "org_study_id": "IR-C-STENT-MBO-83272121"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Stenting combined with brachytherapy", 
                    "Stenting only"
                ], 
                "description": "Comparison of a self-expandable metallic biliary stent loaded with 125 iodine seeds or a self-expandable metallic stent insertion in patients with inoperable cholangioma.", 
                "intervention_name": "Stenting", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Stenting combined with brachytherapy", 
                "intervention_name": "self-expandable metallic biliary stent loaded with 125 iodine seeds", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Stenting only", 
                "intervention_name": "conventional biliary self-expandable stent", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Stenting combined with brachytherapy", 
                "intervention_name": "brachytherapy", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Iodine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cholangiocarcinoma", 
            "Obstruction/stricture", 
            "Stent", 
            "Brachytherapy", 
            "Bile duct"
        ], 
        "lastchanged_date": "December 4, 2013", 
        "location": {
            "contact": {
                "last_name": "haidong zhu"
            }, 
            "facility": {
                "address": {
                    "city": "Nanjing", 
                    "country": "China", 
                    "state": "Jiangsu", 
                    "zip": "210009"
                }, 
                "name": "Zhongda Hospital,Southeast University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of Stent Insertion Combined With or Without Brachytherapy in Patients With Inoperable Malignant Biliary Obstruction Caused by Cholangiocarcinoma", 
        "overall_contact": {
            "email": "zhuhaidong9509@163.com", 
            "last_name": "haidong zhu, Ph.D."
        }, 
        "overall_official": {
            "affiliation": "Zhongda Hospital,Southeast University", 
            "last_name": "Gao-jun Teng, Ph.D,MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Time from stenting to the day when stricture/obstruction of the stent occured or restricture/reobstruction after recanalization the obstructed stent.", 
            "measure": "Patency", 
            "safety_issue": "No", 
            "time_frame": "Participants will be followed till die or lost to follow-up,an expected average of a year."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02001779"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Zhongda Hospital", 
            "investigator_full_name": "Gao-jun Teng", 
            "investigator_title": "Professor of Radiology & Chair,Department of Radiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Time from stenting to the day when the patients died or lost to the follow-up.", 
                "measure": "Over survival", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed till die or lost to follow-up,an expected average of a year."
            }, 
            {
                "description": "The rate of relief of the symptoms and signs of the patients.", 
                "measure": "Clinical success", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed till die or lost to follow-up,an expected average of a year."
            }, 
            {
                "description": "Including technique success rate,side effect/complication,radioactive safety.", 
                "measure": "Safety", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed till die or lost to follow-up,an expected average of a year."
            }
        ], 
        "source": "Zhongda Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Zhongda Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}